Abstract
Abstract: Measles remains one of the most contagious viral diseases worldwide despite the availability of effective vaccination programs. In recent years, outbreaks of measles have been increasingly reported among adults, where the disease is often associated with a more severe clinical course and a higher incidence of complications. Respiratory complications are among the most common and clinically significant consequences of measles infection in adults. These complications include pneumonia, bronchitis, laryngotracheitis, and acute respiratory distress syndrome (ARDS), which may substantially increase morbidity and mortality. The present article reviews the frequency, pathogenesis, clinical manifestations, laboratory characteristics, and outcomes of respiratory complications in adult patients with measles. Particular attention is given to the role of measles-induced immunosuppression in the development of secondary bacterial infections and severe pulmonary involvement. Early diagnosis and timely treatment of respiratory complications are essential for improving patient outcomes and reducing the burden of measles-related morbidity.
References
1. World Health Organization (WHO). Measles Fact Sheet. Geneva: WHO; 2024.
2. Moss WJ. Measles. Lancet. 2017;390(10111):2490–2502.
3. Griffin DE. The Immune Response in Measles: Virus Control, Clearance and Protective Immunity. Viruses. 2016;8(10):282.
4. Strebel PM, Orenstein WA. Measles. New England Journal of Medicine. 2019;381(4):349–357.